You are in PORTALS Women's Imaging Shear-wave Elastography Improves Second-Viewing of Breast US

Shear-wave Elastography Improves Second-Viewing of Breast US

E-mail Print PDF


shearwaveOhio researches have discovered that by adding shear-wave elastography to a second-viewing breast ultrasound study conducted after dynamic contrast-enhanced MRI (DCE-MRI) can identify almost a third more cancers than B-mode ultrasound.

A study of 73 women showed, shear-wave elastography bumped up cancer identification on a second-viewing ultrasound by 31%.

Director of breast imaging at University Hospitals Case Medical Center in Cleveland, Dr. Donna Plecha noted shear-wave elastography has a high negative predictive value, increasing the prospects that findings will have a correlation with pathology; and its ability to detect subtle cancers during second-look ultrasound after DCE-MRI.

Following DCE-MRI, second-look ultrasound offers visualization of lacerations and gives-way to instant ultrasound-directed biopsy. Shear-wave elastography assesses rigidity by determining proliferation shear waves within tissue.

Therefore 73 women (ages 21-84 with average age of 52) received shear-wave elastography during their second-look ultrasound after one or more abrasions were found on DCE-MRI.

MRI studies were carried-out on either a Magnetom Avanto or Magnetom Espree 1.5-tesla scanner using a specialized breast coil. Lacerations that were BI-RADS category 4 and 5 after DCE-MRI were assessed using second-look ultrasound, with both B-mode ultrasound and shear-wave elastography completed using an Aixplorer ultrasound system with a 12-5 MHz linear-array transducer.

Patients were originally scanned with B-mode ultrasound and if a correlation existed with the MRI-detected lesion, then shear-wave elastography was deployed to charter tissue rigidity.

Qualitative color shear-wave elastographic rigidity was used for all lacerations using a five-point color-scheme of highest elasticity in the accumulation and surrounding parenchyma.

All 96 lacerations were given ultrasound-guided or MRI-guided core biopsy and researchers documented pathology outcomes for all lacerations. Of the 96 lacerations, 28 (29%) were malignancies, 14 (14%) were high-risk lesions, and 55 (57%) were benign.

Assembling elastography findings into weaker abrasions (elastography color scale of 1 or 2) and stronger abrasions (elastography color scale of 3, 4, and 5), shear-wave elastography had sensitivity of 95.2%, specificity of 70%, positive predictive value of 71.4%, and negative predictive value of 91%.

Abrasions seen on second-look ultrasound were more likely to be of a cancerous origin than those seen only on MRI (p = 0.006). Shear-wave elastography detected five of the 50 abrasions seen on second-look ultrasound, all of which were invasive cancer. Four were invasive ductal carcinoma and one was an invasive lobular carcinoma.

Of the abrasions detected with DCE-MRI, 84 (87%) were masses; 48 (57%) were also found on second-look ultrasound, thus eliminating the need for an MRI biopsy. The remaining 12 (13%) were nonmass developments, with two (17%) detected on ultrasound. Ultrasound was significantly more likely to find mass enhancement (p = 0.012).

"Ultrasound-guided biopsy of DCE-MRI BI-RADS category 4 or 5 lesions remains preferable to MRI biopsy because of its relative ease, lower cost, and improved patient comfort. The high negative predictive value of the five-point color score of maximum elasticity may help with the confidence level of the radiologist when correlating a benign biopsy result with the B-mode ultrasound image, said Plecha.

For now the next stage of research for Plecha and her team is to involve more patients in an attempt to raise statistical significance.

These signals are relayed buying clomid online safe which then is by a number of such as medial preoptic and paraventricular nulcei.